Thyroid scan is a good tool for diagnosis of hyperfunctioning thyroid nodules (HNs), however it has been limited in use in a primary clinical practice, because of its inconvenience and low accessibility. This study aimed to analyze ultrasonographic (US) characteristics of HNs and to predict HNs by US. Materials and Methods: We included 114 patients who exhibited results of 'hot' nodule in the thyroid scan from 2008 to 2017. Analysis for US characteristics included 73 patients without unclear US images and other inevitable reasons. We compared US characteristics of HNs with cold nodules that showed "cold" in the thyroid scan. Additionally, we compared US characteristics of HNs between suppressed thyroid-stimulating hormone (TSH) (＜0.25 uIU/mL) or normal TSH, and analysis receiver operating characteristics (ROC) curve for prediction of suppressed TSH among HNs. Results: The HNs showed more partially cystic nodule, isoechoic echogenicity, hypervascularity and presence of halo in the US finding than the cold nodule. In subgroup analysis of nodules with TSH suppression among HNs, the TSH suppression nodules was lager in max size and volume than the normal TSH nodules. In ROC analyses for prediction of the TSH suppression among HNs, area under receiver operating characteristics curves was 0.736 in max size, 0.761 in volume. Conclusion: HNs showed more frequently partially cystic contents, isoechoic echogenicity, hypervascularity, and peripheral halo sign in US finding. Thyroid nodule size and volume were associated with suppressed TSH level of HNs, and optimal cutoff levels for prediction of TSH suppression among HNs were 2.6 cm and 1.13 cm 3 , respectively.
Introduction
Hyperfunctioning thyroid nodules (HNs) are defined as nodules that grow and produce thyroid hormone independently of thyroid-stimulating hormone (TSH). [1] [2] [3] HNs can only be diagnosed on thyroid scan and appear as "hot spots" that can be differentiated from surrounding normal thyroid tissue. 4) However, physi-cians in primary clinics cannot diagnose HNs easily because thyroid scans are inconvenient to perform and are limited in access.
Thyroid ultrasonography (US) is widely available, has high accessibility, poses no radiation hazards, and can clearly differentiate thyroid nodules. 5) Therefore, thyroid US is most frequently used to diagnose thyroid nodules. [1] [2] [3] If the ultrasonographic characteristics of HNs can be clarified to enable prediction of HNs, US would be useful in diagnosing and managing thyroid nodule with TSH suppression, especially in primary care settings where thyroid scan is not available.
However, a few studies have accurate analyzed US characteristics of HNs. 6, 7) For this reason, it was necessary to identify the US characteristics of HNs and to analyze the characteristics of the nodule with TSH suppression.
We examined the differences in clinical and sonographical characteristics between HNs and cold nodules on thyroid scan. And the clinical and US characteristics associated with TSH suppression were analyzed, among patients with HNs. As a results, we aimed to describe the usefulness of US in the diagnosis for HNs.
Materials and Methods

Subjects
Among 114 patients with HNs who exhibited "hot"
and "hyperfunction" results on thyroid scan imaging between 2008 and 2017, 73 were included in the analysis. Forty-one patients were excluded for the following reasons: no thyroid US was conducted within 3 months before or after the scan; the location of the nodule seen on the scan and the US did not agree 
Results
Comparison of Clinical Characteristics between HNs and Cold Nodules
There were no significant differences in age and female proportion between patients with HNs and those with cold nodules ( 
Comparison of US Features between HNs and Cold Nodules
Both nodule size and volume were not different between the two groups; there were also no differences in the location of thyroid nodules (Table 1) . HNs exhibited partially solid or cystic features more frequently than cold nodules (50.7% vs. 33.0%, respectively; p= 0.004). Suspicious features, including nodule shape, "irregular," and "taller than wide" were more frequently observed in cold nodules than in HNs (17.6% vs. 5.5%, respectively; p=0.010). In particular, the "taller than wide" shape was not observed in HNs.
The proportion of nodules with hypo-echogenicity (p＜ 0.001) and internal calcification (p=0.019) were higher in cold nodules than in HNs, with a difference that was statistically significant. Internal or peripheral hypervascularity was observed in 95.8% of HNs compared to 44.8% of cold nodules (p＜0.001). Peripheral halo was observed more frequently in HNs than in cold nodules (37.0% vs. 21.3%, respectively; p=0.009).
However, there were no significant differences in nodule margin and echotexture between the groups.
According to the malignancy risk stratification from the ATA guideline, cold nodules exhibited a higher frequency of cases with "highly suspicious" or "intermediate suspicious" categories than HNs. In particular, there were no cases of the "highly suspicious" category in HNs. The number of patients with malignant thyroid nod-ules was 2 (2.7%) in the HN group, and 18 (9.6%) in the cold nodule group. Fig. 2 . Area under receiver operating curve (ROC) of max size and volume to predict thyroid stimulating hormone suppression in hyperfunctioning thyroid nodules were 0.736 (95% CI=0.664-0.879, p＜0.001) and 0.761 (95% CI=0.698-0.906, p＜0.001), respectively.
Comparison of FNA Results or Surgery between HNs and Cold Nodules
Comparison of Clinical and US Characteristics of HNs between Patients with Suppressed versus Normal Levels of TSH
Data from a total of 60 subjects, excluding 13 subjects with multiple nodular goiters, are shown in Table   3 . According to the definition of TSH suppression (TSH 6) reported that HNs showed isoechoic echogenicity and the others also reported that HNs showed partially cystic contend in thyroid US. 10, 11) Previous studies have attempted to identify HNs with other diagnostic tool, such as US-elastography 12) and computed tomography (CT). 13) Guidelines recommend that patients with suppressed TSH level should be examined by thyroid scan for the differential diagnosis of HNs. 2) Our results Fig. 3 . A case of hyperfunctioning thyroid nodule which showed TSH suppressed as size increased. In 2003, TSH of the patient with 1.63 cm isoechoic nodule on thyroid ultrasound (A) was 1.72 uIU/ml in the normal range. In 2012, the size was increased to 2.67 cm mixed isoechoic nodule on ultrasound (B), and the thyroid scan showed hyperfunctioning thyroid nodule (C) and TSH decreased to 0.01 uIU/ml. 3 cm) . 15) The close association between nodule size and degree of TSH suppression was observed well in a representative case, that a 30-year old women with a HN had showed normal TSH level for nine years, then TSH level gradually decreased as the nodule size increased (Fig. 3 ).
We showed optimal size and volume of HNs to predict the status of suppressed TSH, using a ROC curve analysis.
In our study, according to the ATA estimated malignancy classification criteria, US images of HNs were mainly classified as "very low suspicious" or "low suspicious" categories, compared to cold nodules (75.3% and 56.9%, respectively). Interestingly, there were no HNs in high suspicion category; whereas 13.8% of cold nodules were classified into high suspicion category. Low rates of suspicious nodules in HNs are consistent with previous studies that reported very low rates of malignancy. 16, 17) However, we found two malignancy cases (minimally invasive follicular carcinoma and papillary thyroid carcinoma) in patients with
HNs. Including three patients who had incidental PTC, there were 5 (6.8%) malignancy cases in patients with
HNs, corresponding to a previous study that reported malignancy rate of 6.5% of HNs. 7) Because of these non-negligible proportion of malignancy of HNs, US examination might be useful in patients with HNs.
Our study has several limitations. Firstly, this study was designed as a retrospective study in a single hospital, which can lead to selection bias. Secondly, thyroid scan had low interobserver agreement rates, resulting from potential imbalance in radioiodine uptake. 18) However, in our study, thyroid scan images were analyzed by one nuclear medicine specialist, which could have mitigated interobserver issues.
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Additionally, to mitigate this limitation, we excluded patients who have TSH receptor auto-antibodies or multi-nodular characteristics.
In conclusion, US could be a useful diagnostic for HNs in primary care settings where thyroid scan is not available. HNs are most likely to have isoechoic characteristic with mixed-type content and to show hypervascularity on US. TSH suppression is likely to be observed in large HNs larger than 2.6 cm in size or greater 1.13 cm 3 .
